EyePoint Pharmaceuticals Inc (EYPT)
16.75
+0.59
(+3.65%)
USD |
NASDAQ |
Apr 26, 16:00
16.72
-0.02
(-0.15%)
After-Hours: 20:00
EyePoint Pharmaceuticals Max Drawdown (5Y): 93.95% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 93.95% |
| February 29, 2024 | 93.95% |
| January 31, 2024 | 93.95% |
| December 31, 2023 | 93.95% |
| November 30, 2023 | 93.95% |
| October 31, 2023 | 93.95% |
| September 30, 2023 | 93.95% |
| August 31, 2023 | 93.95% |
| July 31, 2023 | 93.95% |
| June 30, 2023 | 93.95% |
| May 31, 2023 | 93.95% |
| April 30, 2023 | 93.95% |
| March 31, 2023 | 93.95% |
| February 28, 2023 | 93.71% |
| January 31, 2023 | 93.71% |
| December 31, 2022 | 93.71% |
| November 30, 2022 | 92.21% |
| October 31, 2022 | 92.21% |
| September 30, 2022 | 92.21% |
| August 31, 2022 | 92.21% |
| July 31, 2022 | 92.21% |
| June 30, 2022 | 92.21% |
| May 31, 2022 | 92.21% |
| April 30, 2022 | 92.21% |
| March 31, 2022 | 92.21% |
| Date | Value |
|---|---|
| February 28, 2022 | 92.21% |
| January 31, 2022 | 92.21% |
| December 31, 2021 | 92.21% |
| November 30, 2021 | 92.21% |
| October 31, 2021 | 92.21% |
| September 30, 2021 | 92.21% |
| August 31, 2021 | 92.21% |
| July 31, 2021 | 92.21% |
| June 30, 2021 | 92.21% |
| May 31, 2021 | 92.21% |
| April 30, 2021 | 92.21% |
| March 31, 2021 | 92.21% |
| February 28, 2021 | 92.21% |
| January 31, 2021 | 92.21% |
| December 31, 2020 | 92.21% |
| November 30, 2020 | 92.21% |
| October 31, 2020 | 92.21% |
| September 30, 2020 | 90.01% |
| August 31, 2020 | 89.21% |
| July 31, 2020 | 85.37% |
| June 30, 2020 | 84.29% |
| May 31, 2020 | 84.23% |
| April 30, 2020 | 84.23% |
| March 31, 2020 | 81.70% |
| February 29, 2020 | 80.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
80.86%
Minimum
Apr 2019
93.95%
Maximum
Mar 2023
89.81%
Average
92.21%
Median
Oct 2020
Max Drawdown (5Y) Benchmarks
| INVO Bioscience Inc | 99.83% |
| Bio-Path Holdings Inc | 99.48% |
| Ocular Therapeutix Inc | 94.06% |
| Aileron Therapeutics Inc | 99.06% |
| Apellis Pharmaceuticals Inc | 74.65% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.51 |
| Beta (5Y) | 1.642 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 155.0% |
| Historical Sharpe Ratio (5Y) | 0.006 |
| Historical Sortino (5Y) | 0.0231 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.15% |